Full Library
Respiratory Syncytial Virus in Transplant: Stopping the Short-Term Spread, Solving the Longer-Term Problems
Resource type
Book Section
Authors/contributors
- Morris, Michele I. (Editor)
- Kotton, Camille Nelson (Editor)
- Wolfe, Camille (Editor)
- Wright, A. J. (Author)
- Mah, A. (Author)
Title
Respiratory Syncytial Virus in Transplant: Stopping the Short-Term Spread, Solving the Longer-Term Problems
Abstract
Respiratory syncytial virus (RSV) causes significant morbidity and mortality in immunocompromised hosts with particular burden among allogeneic hematopoietic stem cell transplant and lung transplant recipients. Affected patients have a substantial risk of secondary infection, ICU admission, or death. Improved diagnostic testing with better sensitivity has given new insights into the epidemiology of disease. In particular, it has highlighted the issue of nosocomial transmission and hospital outbreaks. These can be challenging to manage. Currently, treatment options include ribavirin and immunoglobulin replacement.
Book Title
Emerging Transplant Infections
Date
2021
Publisher
Springer International Publishing
Place
Cham
Pages
725-742
ISBN
978-3-030-01751-4
Accessed
10/23/21, 9:35 AM
Short Title
Respiratory Syncytial Virus in Transplant
Language
en
Library Catalog
DOI.org (Crossref)
Extra
Citation
Wright, A. J., & Mah, A. (2021). Respiratory Syncytial Virus in Transplant: Stopping the Short-Term Spread, Solving the Longer-Term Problems. In M. I. Morris, C. N. Kotton, & C. Wolfe (Eds.), Emerging Transplant Infections (pp. 725–742). Springer International Publishing. https://doi.org/10.1007/978-3-030-01751-4_31-1
TEXTBOOKS
Link to this record